PYM1

Partner of Y14 and mago · Q9BRP8 · PYM1 on Sugi Atlas →

0 patent compounds predicted against PYM1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to PYM1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in 18-59 Year Olds PHASE3ACTIVE_NOT_RECRUITING
Melpida: Recombinant Adeno-associated Virus (serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt) PHASE1/PHASE2RECRUITING
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma PHASE1/PHASE2RECRUITING
Ruxolitinib in Combination With Trastuzumab in Metastatic HER2 Positive Breast Cancer PHASE1/PHASE2COMPLETED
Study Evaluating Toxicity & Efficacy of Lenalidomide(Revlimid®)in Chemotherapy-Naïve AIPC Patients PHASE2COMPLETED
To Evaluate the Effect of Food on the Pharmacokinetics of Y-4 Tablets in Healthy Subjects PHASE1RECRUITING
FAK Inhibitor in Patients With Advanced Solid Tumors PHASE1NOT_YET_RECRUITING
Phase I Study of Novel Estrogen Receptor(ER) a36 Modifier Icaritin in Advanced Breast Cancer Patients PHASE1UNKNOWN
Study of a c-Met Inhibitor PLB1001 in Patients With PTPRZ1-MET Fusion Gene Positive Recurrent High-grade Gliomas PHASE1COMPLETED
Evaluate the Safety, Tolerability, Pharmacokinetic Profile, Efficacy of Bl-M11D1 PHASE1RECRUITING
Safety and Pharmacokinetics of Y-4 Tablets in Healthy Subjects PHASE1RECRUITING
Safety and Efficacy of the Fully Humanized Anti - VEGF Monoclonal Antibody LYN00101 PHASE1WITHDRAWN
Bristol-Myers Squibb Dasatinib Src Inhibition in Endometrial Cancer EARLY_PHASE1COMPLETED
MERC Proteins in Saliva and GCF in Periodontal Disease (ELISA Study) nanCOMPLETED
Immune Cell Response to Stimuli nanRECRUITING
Study of the Genetic and Epigenetic Causes of Recurrent Hydatidiform Moles nanACTIVE_NOT_RECRUITING
Pertuzumab in First Line Treatment of HER2-positive Metastatic Breast Cancer Patients nanUNKNOWN
Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA nanRECRUITING
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus nanCOMPLETED
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Dynamics of Muscle Mitochondria in Type 2 Diabetes Exercise nanCOMPLETED
Genetic Analysis of Inherited Urologic Malignant Disorders: Collection of Samples nanCOMPLETED
Genetic Analysis of Heart Channelopathies in Brazilian Patients and Their Relatives nanUNKNOWN
Study of the Pathophysiological Mechanisms Involved in Bleeding Events nanCOMPLETED
Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others nanRECRUITING
Genetic and Protein Profiling in Normal and Cancerous Breast Tissue nanCOMPLETED
Monogenic Diabetes Misdiagnosed as Type 1 nanRECRUITING
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
Changes in Skin Innervation of Neurologically Asymptomatic Type 2 Diabetic Patients: the Correlation With the Diabetic Parameters and Neurotrophins. nanUNKNOWN
A Retrospective Study to Determine the Incidence of NTRK Fusions. NTRK Study nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a PYM1 binder may also engage these)

ProteinNameSimilarity
Q8CHP5 0.999 Q8CHP5 →
A6QPH1 0.995 A6QPH1 →
Q6PH11 0.995 Q6PH11 →
Q640E9 0.990 Q640E9 →
B5XG19 0.989 B5XG19 →
B5XDD3 0.989 B5XDD3 →
Q9LPZ4 0.988 Q9LPZ4 →
P82804 0.987 P82804 →
B1WB17 0.986 B1WB17 →
Q5R5V9 0.985 Q5R5V9 →
D3ZSC8 0.985 D3ZSC8 →
Q99PT3 0.984 Q99PT3 →
A0JMK9 0.984 A0JMK9 →
Q28E45 0.984 Q28E45 →
B0WII7 0.983 B0WII7 →
Q0VBD2 0.983 Q0VBD2 →
Q5EAW4 0.983 Q5EAW4 →
Q9C086 0.982 Q9C086 →
Q62481 0.982 Q62481 →
B4NSP6 0.982 B4NSP6 →
Q2KI83 0.982 Q2KI83 →
Q08E13 0.981 Q08E13 →
NFRKB Nuclear factor related to kappa-B-binding protein 0.981 landscape →
Q8IWZ8 0.981 Q8IWZ8 →
Q8VDP4 0.981 Q8VDP4 →
Q16LW2 0.981 Q16LW2 →
Q9CYA6 0.981 Q9CYA6 →
Q66HA5 0.981 Q66HA5 →
Q4V882 0.981 Q4V882 →
Q80ZX8 0.981 Q80ZX8 →